Active Ingredient: BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Proprietary Name: BACITRACIN ZINC-NEOMYCIN SULFATE-POLYMYXIN B SULFATE
Dosage Form; Route of Administration: OINTMENT; TOPICAL
Strength: 400 UNITS/GM;EQ 3.5MG BASE/GM;5,000 UNITS/GM
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A062833
Product Number: 001
Approval Date: Nov 9, 1987
Applicant Holder Full Name: NASKA PHARMACAL CO INC DIV RUGBY DARBY GROUP COSMETICS
Marketing Status:
Discontinued
Patent and Exclusivity Information
